Thin Film Drugs Market 2027 By Drug Type, Disease Indication and Geography | The Insight Partners

Thin Film Drugs Market to 2027 - Global Analysis and Forecasts By Drug Type (Oral Thin Film, Transdermal Thin Film, Others); Disease Indication (Schizophrenia, Migraine, Opioid Dependence, Nausea and Vomiting, Others) and Geography

Report Code: TIPRE00006208 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming
MARKET INTRODUCTION

Thin film drugs are relatively new form of drugs that includes encapsulation of tablets or capsules with thin polymer coating. These drugs rapidly dissolves when placed in the buccal cavity resulting in fast systemic circulation. Major pharmaceutical companies are switching their traditional tablets to drugs with fast dissolving oral thin films. These drugs eliminates the problems of swallowing among geriatric and pediatric patients.

MARKET DYNAMICS

The thin film drugs market is anticipated to grow in the forecast, owing to lower manufacturing costs of these drugs, increasing adoption of thin film drugs and various advantages offered by the dosage forms. In addition, the efforts towards improving therapeutic outputs of the drugs is expected to offer significant growth opportunities in the market during the forecast period.

MARKET SCOPE

The "Global Thin Film Drugs Market Analysis to 2027" is a specialized and in-depth study of the medical device industry with a special focus on the global market trend analysis. The report aims to provide an overview of thin film drugs market with detailed market segmentation by drug type, disease indication and geography. The global thin film drugs market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading thin film drugs market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The global thin film drugs market is segmented on the basis of drug type and disease indication. Based on drug type, the market is segmented as oral thin film, transdermal thin film and others. Based on disease indication, the market is segmented into schizophrenia, migraine, opioid dependence, nausea & vomiting, others.

REGIONAL FRAMEWORK


The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global thin film drugs market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The thin film drugs market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting thin film drugs market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the thin film drugs market in these regions.

MARKET PLAYERS


The reports cover key developments in the thin film drugs market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market payers from thin film drugs market are anticipated to lucrative growth opportunities in the future with the rising demand for thin film drugs market in the global market. Below mentioned is the list of few companies engaged in the thin film drugs market.

The report also includes the profiles of key thin film drugs market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

  •  Pfizer, Inc.
  •  ZIM Laboratories Limited
  •  Novartis AG
  •  Wolters Kluwer
  •  Solvay
  •  Allergan plc
  •  Sumitomo Dainippon Pharma Co., Ltd.
  •  IntelGenx Corp.
  •  Indivior plc
  •  MonoSol Rx

The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.
TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Thin Film Drugs Market - By Drug Type
1.3.2 Thin Film Drugs Market - By Disease Indication
1.3.3 Thin Film Drugs Market - By Region
1.3.3.1 By Country

2. KEY TAKEAWAYS


3. RESEARCH METHODOLOGY


4. THIN FILM DRUGS MARKET LANDSCAPE

4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS

5. THIN FILM DRUGS MARKET - KEY MARKET DYNAMICS

5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS

6. THIN FILM DRUGS MARKET - GLOBAL MARKET ANALYSIS

6.1. THIN FILM DRUGS - GLOBAL MARKET OVERVIEW
6.2. THIN FILM DRUGS - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE

7. THIN FILM DRUGS MARKET - REVENUE AND FORECASTS TO 2027 - DRUG TYPE

7.1. OVERVIEW
7.2. DRUG TYPE MARKET FORECASTS AND ANALYSIS
7.3. ORAL THIN FILM
7.3.1. Overview
7.3.2. Oral Thin Film Market Forecast and Analysis
7.4. TRANSDERMAL THIN FILM
7.4.1. Overview
7.4.2. Transdermal Thin Film Market Forecast and Analysis
7.5. OTHERS
7.5.1. Overview
7.5.2. Others Market Forecast and Analysis

8. THIN FILM DRUGS MARKET - REVENUE AND FORECASTS TO 2027 - DISEASE INDICATION

8.1. OVERVIEW
8.2. DISEASE INDICATION MARKET FORECASTS AND ANALYSIS
8.3. SCHIZOPHRENIA
8.3.1. Overview
8.3.2. Schizophrenia Market Forecast and Analysis
8.4. MIGRAINE
8.4.1. Overview
8.4.2. Migraine Market Forecast and Analysis
8.5. OPIOID DEPENDENCE
8.5.1. Overview
8.5.2. Opioid Dependence Market Forecast and Analysis
8.6. NAUSEA AND VOMITING
8.6.1. Overview
8.6.2. Nausea and Vomiting Market Forecast and Analysis
8.7. OTHERS
8.7.1. Overview
8.7.2. Others Market Forecast and Analysis

9. THIN FILM DRUGS MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS

9.1. NORTH AMERICA
9.1.1 North America Thin Film Drugs Market Overview
9.1.2 North America Thin Film Drugs Market Forecasts and Analysis
9.1.3 North America Thin Film Drugs Market Forecasts and Analysis - By Drug Type
9.1.4 North America Thin Film Drugs Market Forecasts and Analysis - By Disease Indication
9.1.5 North America Thin Film Drugs Market Forecasts and Analysis - By Countries
9.1.5.1 United States Thin Film Drugs Market
9.1.5.1.1 United States Thin Film Drugs Market by Drug Type
9.1.5.1.2 United States Thin Film Drugs Market by Disease Indication
9.1.5.2 Canada Thin Film Drugs Market
9.1.5.2.1 Canada Thin Film Drugs Market by Drug Type
9.1.5.2.2 Canada Thin Film Drugs Market by Disease Indication
9.1.5.3 Mexico Thin Film Drugs Market
9.1.5.3.1 Mexico Thin Film Drugs Market by Drug Type
9.1.5.3.2 Mexico Thin Film Drugs Market by Disease Indication
9.2. EUROPE
9.2.1 Europe Thin Film Drugs Market Overview
9.2.2 Europe Thin Film Drugs Market Forecasts and Analysis
9.2.3 Europe Thin Film Drugs Market Forecasts and Analysis - By Drug Type
9.2.4 Europe Thin Film Drugs Market Forecasts and Analysis - By Disease Indication
9.2.5 Europe Thin Film Drugs Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Thin Film Drugs Market
9.2.5.1.1 Germany Thin Film Drugs Market by Drug Type
9.2.5.1.2 Germany Thin Film Drugs Market by Disease Indication
9.2.5.2 France Thin Film Drugs Market
9.2.5.2.1 France Thin Film Drugs Market by Drug Type
9.2.5.2.2 France Thin Film Drugs Market by Disease Indication
9.2.5.3 Italy Thin Film Drugs Market
9.2.5.3.1 Italy Thin Film Drugs Market by Drug Type
9.2.5.3.2 Italy Thin Film Drugs Market by Disease Indication
9.2.5.4 Spain Thin Film Drugs Market
9.2.5.4.1 Spain Thin Film Drugs Market by Drug Type
9.2.5.4.2 Spain Thin Film Drugs Market by Disease Indication
9.2.5.5 United Kingdom Thin Film Drugs Market
9.2.5.5.1 United Kingdom Thin Film Drugs Market by Drug Type
9.2.5.5.2 United Kingdom Thin Film Drugs Market by Disease Indication
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Thin Film Drugs Market Overview
9.3.2 Asia-Pacific Thin Film Drugs Market Forecasts and Analysis
9.3.3 Asia-Pacific Thin Film Drugs Market Forecasts and Analysis - By Drug Type
9.3.4 Asia-Pacific Thin Film Drugs Market Forecasts and Analysis - By Disease Indication
9.3.5 Asia-Pacific Thin Film Drugs Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Thin Film Drugs Market
9.3.5.1.1 Australia Thin Film Drugs Market by Drug Type
9.3.5.1.2 Australia Thin Film Drugs Market by Disease Indication
9.3.5.2 China Thin Film Drugs Market
9.3.5.2.1 China Thin Film Drugs Market by Drug Type
9.3.5.2.2 China Thin Film Drugs Market by Disease Indication
9.3.5.3 India Thin Film Drugs Market
9.3.5.3.1 India Thin Film Drugs Market by Drug Type
9.3.5.3.2 India Thin Film Drugs Market by Disease Indication
9.3.5.4 Japan Thin Film Drugs Market
9.3.5.4.1 Japan Thin Film Drugs Market by Drug Type
9.3.5.4.2 Japan Thin Film Drugs Market by Disease Indication
9.3.5.5 South Korea Thin Film Drugs Market
9.3.5.5.1 South Korea Thin Film Drugs Market by Drug Type
9.3.5.5.2 South Korea Thin Film Drugs Market by Disease Indication
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Thin Film Drugs Market Overview
9.4.2 Middle East and Africa Thin Film Drugs Market Forecasts and Analysis
9.4.3 Middle East and Africa Thin Film Drugs Market Forecasts and Analysis - By Drug Type
9.4.4 Middle East and Africa Thin Film Drugs Market Forecasts and Analysis - By Disease Indication
9.4.5 Middle East and Africa Thin Film Drugs Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Thin Film Drugs Market
9.4.5.1.1 South Africa Thin Film Drugs Market by Drug Type
9.4.5.1.2 South Africa Thin Film Drugs Market by Disease Indication
9.4.5.2 Saudi Arabia Thin Film Drugs Market
9.4.5.2.1 Saudi Arabia Thin Film Drugs Market by Drug Type
9.4.5.2.2 Saudi Arabia Thin Film Drugs Market by Disease Indication
9.4.5.3 U.A.E Thin Film Drugs Market
9.4.5.3.1 U.A.E Thin Film Drugs Market by Drug Type
9.4.5.3.2 U.A.E Thin Film Drugs Market by Disease Indication
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Thin Film Drugs Market Overview
9.5.2 South and Central America Thin Film Drugs Market Forecasts and Analysis
9.5.3 South and Central America Thin Film Drugs Market Forecasts and Analysis - By Drug Type
9.5.4 South and Central America Thin Film Drugs Market Forecasts and Analysis - By Disease Indication
9.5.5 South and Central America Thin Film Drugs Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Thin Film Drugs Market
9.5.5.1.1 Brazil Thin Film Drugs Market by Drug Type
9.5.5.1.2 Brazil Thin Film Drugs Market by Disease Indication
9.5.5.2 Argentina Thin Film Drugs Market
9.5.5.2.1 Argentina Thin Film Drugs Market by Drug Type
9.5.5.2.2 Argentina Thin Film Drugs Market by Disease Indication

10. INDUSTRY LANDSCAPE

10.1. MERGERS AND ACQUISITIONS
10.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
10.3. NEW PRODUCT LAUNCHES
10.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS

11. THIN FILM DRUGS MARKET, KEY COMPANY PROFILES

11.1. PFIZER, INC.
11.1.1. Key Facts
11.1.2. Business Description
11.1.3. Products and Services
11.1.4. Financial Overview
11.1.5. SWOT Analysis
11.1.6. Key Developments
11.2. ZIM LABORATORIES LIMITED
11.2.1. Key Facts
11.2.2. Business Description
11.2.3. Products and Services
11.2.4. Financial Overview
11.2.5. SWOT Analysis
11.2.6. Key Developments
11.3. NOVARTIS AG
11.3.1. Key Facts
11.3.2. Business Description
11.3.3. Products and Services
11.3.4. Financial Overview
11.3.5. SWOT Analysis
11.3.6. Key Developments
11.4. WOLTERS KLUWER
11.4.1. Key Facts
11.4.2. Business Description
11.4.3. Products and Services
11.4.4. Financial Overview
11.4.5. SWOT Analysis
11.4.6. Key Developments
11.5. SOLVAY
11.5.1. Key Facts
11.5.2. Business Description
11.5.3. Products and Services
11.5.4. Financial Overview
11.5.5. SWOT Analysis
11.5.6. Key Developments
11.6. ALLERGAN PLC
11.6.1. Key Facts
11.6.2. Business Description
11.6.3. Products and Services
11.6.4. Financial Overview
11.6.5. SWOT Analysis
11.6.6. Key Developments
11.7. SUMITOMO DAINIPPON PHARMA CO., LTD.
11.7.1. Key Facts
11.7.2. Business Description
11.7.3. Products and Services
11.7.4. Financial Overview
11.7.5. SWOT Analysis
11.7.6. Key Developments
11.8. INTELGENX CORP.
11.8.1. Key Facts
11.8.2. Business Description
11.8.3. Products and Services
11.8.4. Financial Overview
11.8.5. SWOT Analysis
11.8.6. Key Developments
11.9. INDIVIOR PLC
11.9.1. Key Facts
11.9.2. Business Description
11.9.3. Products and Services
11.9.4. Financial Overview
11.9.5. SWOT Analysis
11.9.6. Key Developments
11.10. MONOSOL RX
11.10.1. Key Facts
11.10.2. Business Description
11.10.3. Products and Services
11.10.4. Financial Overview
11.10.5. SWOT Analysis
11.10.6. Key Developments

12. APPENDIX

12.1. ABOUT THE INSIGHT PARTNERS
12.2. GLOSSARY OF TERMS
The List of Companies

1. Pfizer, Inc.
2. ZIM Laboratories Limited
3. Novartis AG
4. Wolters Kluwer
5. Solvay
6. Allergan plc
7. Sumitomo Dainippon Pharma Co., Ltd.
8. IntelGenx Corp.
9. Indivior plc
10. MonoSol Rx